|
Silence Therapeutics Plc - Company Profile Snapshot
| Company Profile: |
Silence Therapeutics Plc |
| Ticker: |
SLN |
| Exchanges: |
LON |
| 2008 Sales: |
2,208,700 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Diversified Drugs, Cosmetics, & Health Care |
| Country: |
UNITED KINGDOM |
| Employees: |
51 |
Business Description
Silence Therapeutics Plc. The Group's principal activity is researching and developing pharmaceutical products. It focuses on Ribonucleic Acid Interference technology, as it can selectively silence genes linked to the onset of disease, thus leading to the creation of a new class of therapeutic products. The Group is developing two products relating to Age-Related Macular Degeneration and Acute Kidney Injury. The Group operates in the United Kingdom.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
